Friday, October 07, 2016 9:06:54 AM
Hurricane Matthew is a material event for ZIVO that mgmt must now inform shareholders of the level of damage to its production scale up efforts at its pilot facility in Vero Beach Florida.
Matthew I believe hit this area overnight as category 3 hurricane and storm surge on the coast expected to be in the 6-12 ft range.
Reading Dahl revisionist "news" history update of August 24th
>>>>>>>>>
Florida Pilot Production Facility in Full Cultivation Mode
August 24, 2016
An unusually hot summer in Florida created delays in the production scale-up of the Company’s proprietary algal strain as cultivation pond water temperatures exceeded the optimal growth range. Heat exchangers were built and a chiller system was installed by mid-July, and testing resumed in early August. The pilot facility is where the commercial production protocols are developed, forming a significant part of the final product specifications required by the FDA compliance process under regulations promulgated by that agency.
The production protocols become part of the “current Good Manufacturing Practices” or “cGMP” documentation, which is a pharmaceutical manufacturing standard now being applied to dietary supplements and food ingredients. These protocols must be formalized before safety testing can begin, so that the FDA is assured that the same manufacturing practices are observed during commercialization as those used during initial safety testing.
<<<<<<<<<<<<<<<
If this was an "indoor" facility, heat wouldn't be an issue as the climate would be controlled and there wouldn't have been need to add heat exchangers and chillers. Would have also cost a lot of money to build, hence the outdoor pond route.
Dahl's additional revisionist "news" history
>>>>>>>>>>>>>>>
ZIVO Bioscience Scales Up Production at Vero Beach Facility
April 1, 2016
Two 50,000 liter ponds are slated to begin construction at an oceanfront facility in Vero Beach, FL to produce the Company’s proprietary, optimized algal strain for use in FDA compliance studies, customer evaluations, and commercialization. The facility will be supervised by Arizona Center for Algae Technology and Innovation (AzCATI) laboratory manager Dr. Thomas Dempster. Its primary purpose is to develop and refine commercial production protocols necessary to comply with FDA regulations covering dietary supplements and dietary ingredients, as well as to provide algal biomass for testing in animals and humans.
<<<<<<<<<<<<<<
Amazing the "news" that appears on the Zivo website recently from 2016 but nowhere else.
I do not know this with 100% certainty but I believe (as Dahl has not said otherwise) that facility is FIT at Vero Beach
http://research.fit.edu/vbml/
As you can see, the facility is right on the beach and the structures far from secure (but easily replaceable). There are no sand dunes to protect it. Literally right on the water. Now consider storm surge over that sand at 6-12 ft high. FIT suspended its operations due to the hurricane. Area likely has no power, etc .... and may be couple days before people get back in there depending on damage. According to FPL stats right now, 60% of the county where Vero Beach is .... has no power. There where mandatory evacuations for areas near the coast.
So again IMO, Dahl must address it with shareholders as soon as possible, whether good or bad. It is a public event material to the success of the project and company. If the facility is ok and there are few issues and business can resume as usual, great news ! If the opposite and the facility is destroyed and thus the project stopped, delayed ....... INVESTORS NEED TO KNOW. I haven't any doubt the algae strain has been secured at AzCATI and other locations, but having to start the production scale up over again would certainly be a set back ......
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM